The matrix metalloproteinases MMP-1 and MMP-3 are implicated in tissue damage underlying other lung diseases (D'Armiento and others 1992; Dahlen and others 1999; Greenlee and others 2007), placing them as potential therapeutic objectives to reduce lung injury in COVID-19. The gene discussed is MMP3; the disease is COVID-19.